Corneal StainingPhase 4NCT00483795
Pilot Evaluation of Two Multipurpose Solutions in Regards to Corneal Staining
A Phase 4 study testing sodium citrate, sodium chloride, sodium borate, propylene glycol. citrate, tetronic 1304, AMP 95 in people with Corneal Staining, run by Innovative Medical at 1 site in United States.
Trial summary
To evaluate corneal staining after contact lens instillation with two different multi purpose solutions. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Corneal Staining
- What is being tested?
- sodium citrate, sodium chloride, sodium borate, propylene glycol. citrate, tetronic 1304, AMP 95
- How many people
- Not given
- Where
- 1 siteUnited States
- Study dates
- Start not givento not given
- Phase
- Phase 4
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Adult, Older adult
Who may be able to join
- Patients 18 yrs or older
- Males or females
- Any race or ethnic background
- CL patients using (multipurpose solutions) MPS
- Patients using Acuvue 2 lenses
Who cannot join
- Corneal refractive surgery within 6 months of this study.
- Contact lens use on day of examination.
- Corneal ectasia.
- Current use of Restasis
Trial locations and contacts
1 site in 1 country.
United States1 site
Hazleton Eye Specialists
Hazleton, Pennsylvania, 18202
About this study
To evaluate corneal staining after contact lens instillation with two different multi purpose solutions.
- Conditions
- Corneal Staining
- Being tested
- sodium citrate, sodium chloride, sodium borate, propylene glycol. citrate, tetronic 1304, AMP 95
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
sodium citrate, sodium chloride, sodium borate, propylene glycol. citrate, tetronic 1304, AMP 95Drug
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 Jun 2007 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Corneal StainingStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
Sponsor and investigators
- Lead sponsor
- Innovative Medical
- Sponsor type
- Industry (pharma, biotech, devices)
- Investigators
- Thomas Kislan, OD, Principal investigator, Hazleton Eye Specialists
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00483795
- Sponsor's protocol ID
- 5308
- Status last verified
- Jul 2007
- First submitted
- 1 Jun 2007
- Last updated
- 25 Jul 2007
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 25 Jul 2007. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Pilot Evaluation of Two Multipurpose Solutions in Regards to Corneal Staining
- ClinicalTrials.gov ID
- NCT00483795
- Acronym / sponsor ID
- 5308
- Conditions
- Corneal Staining
- Phase
- Phase 4
- Study type
- Interventional
- Recruitment status
- Completed
- Lead sponsor
- Innovative MedicalIndustry (pharma, biotech, devices)
- First posted
- 7 Jun 2007 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
To evaluate corneal staining after contact lens instillation with two different multi purpose solutions.
Study design
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- Patients 18 yrs or older
- Males or females
- Any race or ethnic background
- CL patients using (multipurpose solutions) MPS
- Patients using Acuvue 2 lenses
Key exclusion criteria (4 listed)
- Corneal refractive surgery within 6 months of this study.
- Contact lens use on day of examination.
- Corneal ectasia.
- Current use of Restasis
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| sodium citrate, sodium chloride, sodium borate, propylene glycol. citrate, tetronic 1304, AMP 95 | Drug | – |
Primary outcome
Not reported in the source record.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 25 Jul 2007.
Related trials for Corneal Staining
Enrolling by invitationPhase 4
Efficacy of 0.28% Sodium Hyaluronate Eye Drops in Patient With Moderate to Severe Dry Eye
Dry Eye Disease (DED), Tear Break-Up Time
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Thomas Kislan, OD principal investigator
Hazleton Eye Specialists
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 4 study testing sodium citrate, sodium chloride, sodium borate, propylene glycol. citrate, tetronic 1304, AMP 95 in people with Corneal Staining, run by Innovative Medical at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 25 Jul 2007. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Jul 2007; AzTrials last refreshed its copy on 6 Nov 2026.